Therefore, taking advantage of our experimental model that is able to mimic in vivo conditions and the P53 and BMI-1 connection, the aim of the present study was to investigate whether the use of PRIMA-1MET and/or PTC596 could be a new and effective approach to counteract the drug resistance of NB cells by reducing intracellular GSH levels. Here, TP53 is linked to neuroblastoma.